Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment

Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of pro...

Full description

Bibliographic Details
Main Authors: Frederik Uttenthal Larsen, MD, Johannes Katate Wilhjelm, MD, Eric Steen Nielsen, MD
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:JACC: Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084919300464
id doaj-8d570206f3e34025a468090742d30f24
record_format Article
spelling doaj-8d570206f3e34025a468090742d30f242021-06-07T06:53:59ZengElsevierJACC: Case Reports2666-08492019-06-011158Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab TreatmentFrederik Uttenthal Larsen, MD0Johannes Katate Wilhjelm, MD1Eric Steen Nielsen, MD2Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; Address for correspondence: Dr. Frederik Uttenthal Larsen, Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.Department of Cardiology, Viborg Regional Hospital, Viborg, DenmarkDepartment of Cardiology, Viborg Regional Hospital, Viborg, DenmarkMalignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.)http://www.sciencedirect.com/science/article/pii/S2666084919300464cardio-oncologycardiovascular imagingcardiac metastasesimmune checkpoint inhibitors
collection DOAJ
language English
format Article
sources DOAJ
author Frederik Uttenthal Larsen, MD
Johannes Katate Wilhjelm, MD
Eric Steen Nielsen, MD
spellingShingle Frederik Uttenthal Larsen, MD
Johannes Katate Wilhjelm, MD
Eric Steen Nielsen, MD
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
JACC: Case Reports
cardio-oncology
cardiovascular imaging
cardiac metastases
immune checkpoint inhibitors
author_facet Frederik Uttenthal Larsen, MD
Johannes Katate Wilhjelm, MD
Eric Steen Nielsen, MD
author_sort Frederik Uttenthal Larsen, MD
title Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_short Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_full Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_fullStr Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_full_unstemmed Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_sort remission of a perimyocardial melanoma metastasis with pembrolizumab treatment
publisher Elsevier
series JACC: Case Reports
issn 2666-0849
publishDate 2019-06-01
description Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.)
topic cardio-oncology
cardiovascular imaging
cardiac metastases
immune checkpoint inhibitors
url http://www.sciencedirect.com/science/article/pii/S2666084919300464
work_keys_str_mv AT frederikuttenthallarsenmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment
AT johanneskatatewilhjelmmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment
AT ericsteennielsenmd remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment
_version_ 1721392071572455424